Care este prețul pentru TME Pharma N.V. (ALTME)

Prețul pentru TME Pharma N.V. (ALTME) este $0.09489241

Care este capitalizarea de piață pentru TME Pharma N.V. (ALTME)

Capitalizarea de piață pentru TME Pharma N.V. (ALTME) este $8.94M

TME Pharma N.V. (ALTME) Preț și Capitalizare de Piață

TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.

Prețul pentru ALTME	Activul B	Capitalizarea de piață a B	Rezultate
$57,880.05 $8.94M	NVDA	$5.452T	+60,995,345.99%
$47,668.54 $8.94M	AAPL	$4.490T	+50,234,204.30%
$44,190.42 $8.94M	GOOG	$4.162T	+46,568,871.39%
$39,030.09 $8.94M	MSFT	$3.676T	+41,130,785.35%
$30,077.15 $8.94M	AMZN	$2.833T	+31,695,954.80%

Prețul pentru ALTME

Activul B

Capitalizarea de piață a B

Rezultate

$57,880.05 $8.94M